image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k |
|---|---|---|
ab6a760a42658bc9ce805a146a2949577ca54d19d52b33f988209f7235402ea5.png | simple | <table><tr><td> </td><td>AS</td><td>FA</td><td>SS</td><td>AC</td><td>EF</td><td>WO</td><td>CLDQ</td></tr><tr><td>PF</td><td>0.597</td><td>0.762</td><td>0.691</td><td>0.744</td><td>0.636</td><td>0.438</td><td>0.756</td></tr><tr><td>RP</td><td>0.643</td><td>0.717</td><td>0.646</td><td>0.667</td><td>0.614</td><td>0.480</t... |
e846d7b711f36c6af1b5e1ab78a71b8d488b1d0e84d4a0a0c018c3e5cb57acda.png | simple | <table><tr><td>CNVs</td><td>Copy numbers</td><td>Related genes</td><td>Related pathways</td></tr><tr><td>rs2002594; rs1986617</td><td>1</td><td>FAM162A</td><td>Mitochondrial apoptotic cascades</td></tr><tr><td>rs10517547; rs10517548; rs2122642; rs2345041; rs1823535; rs1823536; rs1470724</td><td>1</td><td>LPHN3</td><td>... |
2511a5f77900e871a37c5f222e7dda045f555585bebd743a3f925bf7518fd09e.png | simple | <table><tr><td>Gene symbol</td><td>Description</td><td>Position (Mb)</td><td>MiRNA</td><td>Packages</td></tr><tr><td><i>RNF111</i></td><td>Ring Finger Protein 111</td><td>6.32–6.36</td><td>miR-142-3p</td><td>Targetscan</td></tr><tr><td><i>TCF12</i></td><td>transcription factor 12</td><td>6.90–7.00</td><td>m... |
8033eba3598a07097a50c8fe38db2ac03eb56f5eaf90debf3adebf00784bb9bc.png | complex | <table><tr><td rowspan="2">Compounds</td><td colspan="2">Bradykinin <sup>a</sup></td><td colspan="2">Renin substrate tetra-decapeptide <sup>a</sup></td></tr><tr><td>S/N</td><td>Sig. Int.</td><td>S/N</td><td>Sig. Int.</td></tr><tr><td>1</td><td>711</td><td>56530</td><td>551</td><td>47162</td></tr><tr><td>2</td><td>540</... |
58f398f6ee0a00bf8770fb1efbfd95ec1accfce37df7c0356e622d638f21f22b.png | simple | <table><tr><td>Variable</td><td>Number</td><td>Percentage</td></tr><tr><td>Intravenous drug users</td><td>20</td><td>5.8</td></tr><tr><td>Surgery</td><td>144</td><td>41.6</td></tr><tr><td>Blood transfusion</td><td>40</td><td>11.6</td></tr><tr><td>Transplantation</td><td>1</td><td>0.3</td></tr><tr><td>History of hepatit... |
a98ce093ae9dcefec13920c93c5d6837db621bf6b4b34e3c4d522b9192b7d870.png | complex | <table><tr><td>Variables</td><td colspan="2">Univariate analysis</td><td></td><td colspan="2">Model 1</td><td></td><td colspan="2">Model 2</td></tr><tr><td></td><td>HR (95%CI)</td><td><i>p</i> value</td><td></td><td>HR (95%CI)</td><td><i>p</i> value</td><td></td><td>HR (95%CI)</td><td><i>p</i> value</td></tr><tr><td>Ag... |
43efdb13f7b7070e4a3c8feba82a46f30cb8e4e1809a457c781ab48eaeda9aad.png | complex | <table><tr><td> </td><td colspan="2">Perprotocol</td><td colspan="2">Intention to treat</td></tr><tr><td> </td><td>Odds ratio (95% CI)</td><td><i>P</i> value</td><td>Odds ratio (95% CI)</td><td><i>P</i> value</td></tr><tr><td>Age</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> <60 years old</td><td>1.0 (re... |
0d2884efc9475302b77f01b300ca00e895bb66acc643cb9e65039548023e7ca4.png | simple | <table><tr><td> </td><td>σ (MPa)</td><td><i>STD</i></td><td><sub><i>λ</i></sub></td><td><i>STD</i></td></tr><tr><td>SV- Longitudinal</td><td>5.38</td><td>0.6</td><td>1.32</td><td>0.04</td></tr><tr><td>SV- Circumferential</td><td>2.61</td><td>0.67</td><td>1.55</td><td>0.06</td></tr><tr><td>UV- Longitudinal</td... |
0dfdd110ff0283a2db9a0e580b711d5df8a59223f4340ee75107809e2cd8c107.png | complex | <table><tr><td>Platform</td><td colspan="6">System</td><td colspan="7">Applications</td></tr><tr><td></td><td>IMU</td><td>GPS</td><td>LIDAR</td><td>Camera</td><td>DG payload weights</td><td>Cost</td><td>Large area</td><td>Small area</td><td>Mobility</td><td>Weather limitation</td><td>DG accuracy (3DRMS)</td><td>Cyber c... |
8e3dfd8ae9d185571aa6fdc80f58d59fc7693710d1965ea81cb81606ee0b065c.png | simple | <table><tr><td></td><td>N voxels</td><td>Gray Matter</td><td>White Matter</td><td>CSF</td><td>MD</td><td>axial</td><td>FA</td><td>FW</td><td>radial</td></tr><tr><td>CSF</td><td>117049</td><td>0.1321 ± 0.2485</td><td>0.0044 ± 0.0423</td><td>0.7580 ± 0.2926</td><td>0.0018 ± 0.0009</td><td>0.0022 ±... |
94f93407cf4152a63b2a7c6d1f8fd9a26a79f9897e39955b793846cc0bae489d.png | complex | <table><tr><td rowspan="2">Factors</td><td colspan="3">ANC</td><td colspan="3">Delivery</td></tr><tr><td colspan="3">N = 315</td><td colspan="3">N = 315</td></tr><tr><td></td><td>AOR (95% CI)</td><td>P-value<sup>*</sup></td><td>P-value<sup>**</sup></td><td>AOR (95% CI)</td><td>P-value<sup>*</sup></td><td>P-value<sup>**... |
a208841c966cab6abf3e19feb4bacf05e2e3660d5e87fc86ef22af07cb66e18d.png | simple | <table><tr><td></td><td>Recipient</td><td>Donor</td></tr><tr><td>Male (%)</td><td>37 (74%)</td><td>36 (72%)</td></tr><tr><td>Female (%)</td><td>13 (26%)</td><td>14 (28%)</td></tr><tr><td>Age (yrs)</td><td>51.3 ± 11.1 (16 - 67)</td><td>53.2 ± 17.2 (19 - 86)</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>25.7 ... |
1909e8ec8fa321238d89b5b3ffaffa5bab0ff3572d8f612275431d2e2c39f90a.png | complex | <table><tr><td> </td><td colspan="2">No. of points</td></tr><tr><td>Risk factor</td><td>SITS SICH risk score</td><td>Extended risk score</td></tr><tr><td>Aspirin + clopidogrel</td><td>3</td><td>3</td></tr><tr><td>Aspirin monotherapy</td><td>2</td><td>2</td></tr><tr><td>NIHSS ≥13</td><td>2</td><td>2</td></tr><tr><... |
002f6ac944299a46ab1e94ec1c99f5c9cd7a27237f9fdc25f1b8e09b1110b163.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="2">Level of knowledge</td><td rowspan="2">COR (95% CI)</td><td rowspan="2">AOR (95% CI)</td></tr><tr><td>Adequate</td><td>Inadequate</td></tr><tr><td>Age</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> 15–24</td><td>53 (57%)</td><td>40 (43%)</td><td><... |
a5162ee77a6b42d28d3df1d309a4652f5689c6f288b1b0e690313ab895f19c5a.png | complex | <table><tr><td rowspan="2"></td><td>IL-1</td><td>IL-6</td><td>TNF-α</td><td>IL-10</td><td>TGF-β1</td></tr><tr><td colspan="5">pg/mg</td></tr><tr><td>NC</td><td>10.3 ± 1.2 *</td><td>12.5 ± 2.1 *</td><td>20.7 ± 2.3 *</td><td>265.8 ± 17.9</td><td>16.4 ± 1.8</td></tr><tr><td>SS24</td><td>... |
7e44d073201f65a4fb00b65e8f860671fa8b5b87427882f2e0784e99177c672e.png | complex | <table><tr><td>Treatment</td><td>Flume number</td><td>Field name</td></tr><tr><td>Sustainable intensification</td><td>6</td><td>Golden Rove</td></tr><tr><td rowspan="2">Increased use of legumes</td><td>8</td><td>Higher Wyke Moor and Middle Wyke Moor (reseeding in 2013)</td></tr><tr><td>11</td><td>Dairy East</td></tr><t... |
b5c26992ea8abefba4ab097d94b16db1a2f43d222a27d46ef5d343f2fcbf8b29.png | simple | <table><tr><td>Characteristics</td><td>Count (%)</td></tr><tr><td>Sociodemographic</td><td> </td></tr><tr><td> Gender</td><td> </td></tr><tr><td>Male</td><td>98 (65.3)</td></tr><tr><td>Female</td><td>52 (34.7)</td></tr><tr><td> Age (years)</td><td> </td></tr><tr><td>20–30</td><td>80 (53.3)</td></tr><tr><td>31R... |
e2615be9ada0aa4ca0c92f4a685ee175c237987fa073ef611ddffc4a347183eb.png | complex | <table><tr><td>Variable</td><td colspan="3"><i>PIK3CA </i>mutations (n = 113)</td><td colspan="3"><i>PIK3CA </i>amplification (n = 131)</td></tr><tr><td></td><td>Yes</td><td>No</td><td><i>P</i></td><td>Yes</td><td>No</td><td><i>P</i></td></tr><tr><td>No.of patients</td><td>8</td><td>105</td><td></td><td>88</td><td>43</... |
1c17c2ea151d2c646b33db8266d461a3995c51413504838d9a12b98d404f3d1a.png | simple | <table><tr><td></td><td></td><td>Parametric</td><td>Nonparametric</td></tr><tr><td>Misacylation</td><td></td><td></td><td></td></tr><tr><td></td><td>COVE</td><td>68*</td><td>55</td></tr><tr><td></td><td>resCOVE</td><td>64</td><td>64</td></tr><tr><td></td><td>Spacer</td><td>55</td><td>64</td></tr><tr><td></td><td>Usage<... |
a45c37e33058ebf82522814c0ece62f49f789789919f674ff905b9a195fcf997.png | simple | <table><tr><td> Age/sex</td><td>Comorbidity</td><td>Site</td><td>Culture source</td><td>Therapy</td><td>Outcome</td></tr><tr><td>75/F</td><td>Syringomyelia</td><td>L leg</td><td>Tissue</td><td>Antibiotics, debridement</td><td>Survived</td></tr><tr><td>80/F</td><td>None</td><td>R leg</td><td>Tissue</td><td>Antibiotics, ... |
637a6dc81162c285552953fbad6b3d1706491c111e2e6e1d01f9baa062404bc2.png | complex | <table><tr><td>Outcome</td><td colspan="4">All births</td></tr><tr><td></td><td><i>n</i></td><td>Rate</td><td>OR (95% CI)</td><td>AOR<sup>a</sup> (95% CI)</td></tr><tr><td colspan="5">Umbilical artery pH < 7.10</td></tr><tr><td> Occiput posterior</td><td>56</td><td>5.5</td><td>1.48 (1.12–1.96)</td><td>1.28 (0.... |
a96298098c08dbab3dafb5154396a269dc0b908c335542cfb44f71f61f712da0.png | complex | <table><tr><td rowspan="2">Ages (years)</td><td>Mild/NVI</td><td colspan="2">Low vision</td><td colspan="3">Blindness</td><td rowspan="2">Total VI (%)</td></tr><tr><td>0</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td></tr><tr><td>6–18</td><td>20.8</td><td>1.8</td><td>0.3</td><td>0.8)</td><td>1.5</td><td>0.... |
a5fc90b839b1269cebe1653f7f3775a8e48fa30234c464c3148c50d5bcc25edc.png | complex | <table><tr><td>Material</td><td>Scaffold Preparation</td><td>Shape and Structure of the Scaffold</td><td>Mechanical Properties of the Scaffold</td><td>Ref.</td></tr><tr><td>Collagen</td><td rowspan="3">Freeze drying</td><td>Sponges L = 11, 23 or 51 mm94% porosity, pore size = 62 μm</td><td>For L = 23 mm spec. EM =... |
37049550b9607c9e6a41ec3afeb97cb59a8d36efbca9d93b505f99a66b755f0a.png | complex | <table><tr><td>Demographic characteristics</td><td>Sampled frequency, <i>n</i> (%)</td><td>Weight misperception frequency, <i>n</i> (%)</td></tr><tr><td colspan="3">Sex<sup>a</sup></td></tr><tr><td> Female</td><td>2003 (44.5)</td><td>426 (21.4)</td></tr><tr><td> Male</td><td>2380 (55.5)</td><td>900 (39.1)</td></tr><tr>... |
566b4857a6446e18d3e132fbfe46679cf41156cbeb955474287d7628400eaadc.png | complex | <table><tr><td rowspan="2">Factors</td><td colspan="2">Univariate analysis</td><td colspan="2">Multivariate analysis</td></tr><tr><td>Hazard ratio (95% CI)</td><td><i>P</i> value</td><td>Hazard ratio (95% CI)</td><td><i>P</i> value</td></tr><tr><td>DDA1</td><td>2.747 (1.405–5.372)</td><td>0.003</td><td></td><td>0... |
b28ba28726d00d2c7c1db28d7c2be2a92b0a6484f195136d06998d0365698255.png | simple | <table><tr><td></td><td>Men (n = 58)</td><td>Women (n = 65)</td><td>ANOVA</td><td><i>F</i></td><td><i>p</i></td></tr><tr><td>Bench press</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Pre</td><td>68.7 ± 16.0§</td><td>29.2 ± 6.3</td><td>Group</td><td>378.14</td><td>< 0.001</td></tr><tr><... |
d5ca076dd19f65dc48935f07e96bfff873ded8386a7bbee0b92b78798b9f81b7.png | simple | <table><tr><td>Task</td><td>Group description</td><td>Activity of group 1 higher that group 2</td><td>Activity of group 1 low that group 2</td><td>Reference</td></tr><tr><td>Tactile stimulation</td><td>PD patients (1) vs. healthy control volunteers</td><td>R. primary sensory, R. motor cortex, R. supplementary motor are... |
2cb20b9e8e2d9a817fb7331e9dbe92fe350d81c4f26033d0ae812358ef7ba7d5.png | complex | <table><tr><td colspan="4">Motor nerve conduction</td></tr><tr><td>Nerve</td><td>Latency</td><td>Amplitude</td><td>Conduction velocity</td></tr><tr><td>Median R (wrist)</td><td>8.9 ms</td><td>1.3 mV</td><td> </td></tr><tr><td>Median R (elbow)</td><td>18.5 ms</td><td>0.8 mV</td><td>24 m/s</td></tr><tr><td>Ulnar R (wrist... |
8d61aa2c014ac5e098d184d82b3bb5a7ed708e8850c5cbd6a46f921fcb7f1600.png | complex | <table><tr><td></td><td>R-cases (<i>n</i> = 20)</td><td>6mo-cases (<i>n</i> = 19)<sup>a</sup></td><td>TST+ (<i>n</i> = 9)</td><td>TST− (<i>n</i> = 18)</td></tr><tr><td>Median age, years (range)</td><td>31.5 (17–65)</td><td>30 (18–69)</td><td>42 (20–65)</td><td>22.5 (16–51)</td></tr><tr><td... |
88b36a23e66931081c344444c3fb40df93c2deb2edc939161eb7be321a4cf4e1.png | complex | <table><tr><td></td><td colspan="6">No. of abnormalities</td></tr><tr><td>Abnormality</td><td>Arctic</td><td>Innoko</td><td>Kenai</td><td>Tetlin</td><td>Yukon Delta</td><td>Total</td></tr><tr><td colspan="7">Eye abnormality</td></tr><tr><td> Anophthalmia (missing eye)</td><td>0</td><td>2</td><td>12</td><td>6</td><td>0<... |
642db7628587a733ed3fe500cc1d5f713eca9b980cd2af18dedbe1a000c5984c.png | complex | <table><tr><td rowspan="2">Source</td><td colspan="3">Minerals</td><td colspan="5">Vitamins</td></tr><tr><td>Fe (%)</td><td>Na (%)</td><td>Se (%)</td><td>Riboflavin (%)</td><td>Thiamin (%)</td><td>B12 (%)</td><td>Niacin (%)</td><td>Folic acid (%)</td></tr><tr><td>Red meat<sup>*</sup></td><td>14.5</td><td>13.9</td><td>2... |
a45fb7f3c79f88c8532b79cffb19ce4456e5d823861d9668b33b65c6aa68824e.png | complex | <table><tr><td></td><td colspan="4">pCR prediction(n = 488)</td></tr><tr><td>Prediction evaluation*</td><td>PPV (SD)</td><td>NPV (SD)</td><td>Sensitivity (SD)</td><td>Specificity (SD)</td></tr><tr><td>Unsupervised clustering</td><td></td><td></td><td></td><td></td></tr><tr><td>BRmet50</td><td>93(14)</td><td>34(3)</td><... |
c8f338df17f2aab37fb1e201b8f6350242d962be64308e1f769dc8d57f67faba.png | simple | <table><tr><td>SNP ID</td><td>Chr 16 position sequence</td><td>Sequence</td><td>Type</td><td>Amino acid change</td></tr><tr><td>rs200158701</td><td>70680854(+)</td><td>CCATGC/TCCCGG</td><td>mis</td><td>PS</td></tr><tr><td>rs192337001</td><td>70680866(+)</td><td>GCTTCA/CCCTGG</td><td>mis</td><td>TP</td></tr><tr><td>rs13... |
f41d9718c98a01ba275ff51a6abfea57ab68b73d44d3f94413a05bea76814250.png | complex | <table><tr><td rowspan="2">Groups</td><td>Total cholesterol </td><td>LDL-C</td><td>HDL-C</td><td>TG</td><td>HbA1c</td><td>FBG</td></tr><tr><td><i>r </i>Pearson</td><td><i>r </i>Pearson</td><td><i>r </i>Pearson</td><td><i>r </i>Pearson</td><td><i>r </i>Pearson</td><td><i>r </i>Pearson</td></tr><tr><td>Ox-LDL of normoalb... |
563e267b35a2b55907de85900b91fd35753e25ba53bb7132bf4aaa4011b9ff5f.png | simple | <table><tr><td> </td><td>Survivors(<i>n</i> = 90)</td><td>Former prisoners(<i>n</i> = 83)</td><td><i>Statistics</i></td><td>Descendants of survivors(<i>n</i> = 97)</td><td>Descendants of former prisoners(<i>n</i> = 90)</td><td><i>Statistics</i></td></tr><tr><td>Gender % <i>(n)</i></td><td> </td><td> </td><td> </td><td>... |
eba539bee38f1eb538c25b683833873476807032134086b155854e72a8bcda4a.png | simple | <table><tr><td>SSA</td><td>ST</td><td>t<sub>1</sub>(h)</td><td>μ<sub>e</sub></td><td>STD</td><td>ξ</td><td>STD</td><td>γ</td><td>t<sub>1</sub>(h)</td><td>μ<sub>e</sub></td><td>STD<sup>a</sup></td><td>ξ</td><td>STD</td><td>γ</td></tr><tr><td>3.37</td><td>53.95</td><td>6</td><td>−3.12<... |
052f5788b8f24869a2850e1d6e9fac1d83e6b15612b2103bebe80cdd5cb8a7f4.png | simple | <table><tr><td></td><td>ABFAB</td><td>FBC</td><td>FPH</td><td>Total</td></tr><tr><td>Women who stopped breastfeeding before 6 months</td><td>n = 65</td><td>n = 7</td><td>n = 14</td><td>n = 86</td></tr><tr><td>Stopped bf before mastitis</td><td>5</td><td>1</td><td>2</td><td>8</td></tr><tr><td>Stopped within 3 wks</td><t... |
3646d7c795e184da4148f18c3ff8046272010a472a993df2af9be8ab292814d3.png | complex | <table><tr><td></td><td>Patients</td><td>Controls</td><td>OR*</td><td>95%CI</td><td>OR**</td><td>95%CI</td></tr><tr><td colspan="7">rs117813469</td></tr><tr><td> GG</td><td>186</td><td>198</td><td></td><td></td><td></td><td></td></tr><tr><td> GC/CC</td><td>28</td><td>15</td><td>2.25</td><td>(1.14-4.46)</td><td>2.12</td... |
6a8d2828d9e7d00e12a7059fb53253c67fd2d531c90266b08e00e280dfccae21.png | simple | <table><tr><td></td><td>Pencil</td><td>Oil-pastel</td><td>Gouache</td><td><i>F</i><sup>(2,98)</sup></td></tr><tr><td></td><td>(M/SD)</td><td>(M/SD)</td><td>(M/SD)</td><td></td></tr><tr><td>RSA</td><td>6.23 (± 1.07)</td><td>5.90 (± 0.98)</td><td>6.01 (± 1.09)</td><td>3.58<sup>∗</sup></td></tr><tr><t... |
69035cec5af991caff3f85c0fef1045b3b7e50472b9adffe537ca5f600d11224.png | simple | <table><tr><td>Protein ID</td><td>Orthologs</td><td>Potential functions</td></tr><tr><td>Wolco1| 166770</td><td>STE20</td><td>Growth, virulence, and sclerotial formation</td></tr><tr><td>Wolco1| 43954</td><td>STE11</td><td>Growth, virulence, and sclerotial formation</td></tr><tr><td>Wolco1| 150169</td><td>STE7</td><td>... |
7c9c890d2795eee22c44942bb1d093b7317890e32860b2064085cf37c25ab724.png | simple | <table><tr><td> </td><td>Group A<sup>†</sup>(n = 255)</td><td>Group B<sup>‡</sup>(n = 41)</td><td>p-value</td></tr><tr><td>Mean sUA level (mg/dL)</td><td>4.69 ± 1.08</td><td>7.61 ± 0.95</td><td>< 0.001</td></tr><tr><td>F/U time (months)</td><td>73.0 ± 42.2</td><td>62.0 ± 46.8</td><td>... |
8b348ae8b1b777e848c7eb91106ccebfa5cf70a5c9f9e4d55f3d309a420b0056.png | complex | <table><tr><td rowspan="2">HPV type</td><td colspan="2">Baseline (<i>n</i> = 1759)</td><td colspan="2">Follow-up (<i>n</i> = 85)</td></tr><tr><td><i>N</i></td><td>Prevalence (%)</td><td><i>N</i></td><td>Persistence (%)</td></tr><tr><td>Any type</td><td>152</td><td>8.64</td><td>29/85</td><td>34.12</td></tr><tr><td>High-... |
599eccd4e92c96d38a535c3c4542ac9239b49b9345a844f4d30ad261a3207a0e.png | complex | <table><tr><td>Individual subject characteristics</td><td>Prognostic factors</td><td></td></tr><tr><td></td><td>Age</td><td>Confirmatory</td></tr><tr><td></td><td>Gender</td><td>Exploratory</td></tr><tr><td></td><td>Height, weight, body mass index</td><td>Exploratory</td></tr><tr><td></td><td>Ethnicity/race</td><td>Exp... |
bf79e5230e27ba89b20107a4990b5d1cde206cee0fc7834a6e06362ebb781c03.png | complex | <table><tr><td>Systems</td><td>Plot area (m<sup>2</sup>)</td><td>Gradient (°)</td><td>Aspect</td><td>Agro type (by Chinese system)</td><td>Bulk density (g cm<sup>−3</sup>)</td><td>pH</td><td>OM (g kg<sup>−1</sup>)</td><td>TN (g kg<sup>−1</sup>)</td><td>AN (g kg<sup>−1</sup>)</td><td>TP (g k... |
643298bc18e3a0f00727bd49828afa6697ec7b56576bd71d95b85e0279e1dcac.png | simple | <table><tr><td></td><td>B</td><td>SE</td><td>Significance</td></tr><tr><td>(Constant)</td><td>−0.57</td><td>0.05</td><td></td></tr><tr><td>City of residence</td><td>0.25</td><td>0.06</td><td>0.000*</td></tr><tr><td>Smoker(s) present in the home</td><td>0.12</td><td>0.07</td><td>0.073</td></tr></table> |
58e42727741c5fc90aa109083b40670346939d542eecfeeca1416e21ca6d9deb.png | complex | <table><tr><td rowspan="2">Year</td><td rowspan="2">No. of Samples</td><td rowspan="2">No. of Positive</td><td rowspan="2">Positive Rate (%)</td><td colspan="3">Influenza A Virus</td><td rowspan="2">Influenza B Virus</td></tr><tr><td>H1N1</td><td>H3N2</td><td>pdm H1N1</td></tr><tr><td>2006</td><td>1290</td><td>145</td>... |
763f28988f8d671b242c1522a410a769bbb86ef50ef4dc9668d33ba12edd7068.png | simple | <table><tr><td></td><td>Total, n= 1781</td><td>Wild-type <i>KRAS</i>, n= 1416</td><td>Mutant <i>KRAS</i>, n= 365</td><td>P</td></tr><tr><td>No. of associated alterations</td><td></td><td></td><td></td><td></td></tr><tr><td> Median (range)</td><td>0 (0-9)</td><td>0(0-9)</td><td>1(1-9)</td><td><0.0001</td></tr><tr><td... |
43f85e59472e23bb5bf407049cf64438e3c653957561252e125e645f680f847e.png | complex | <table><tr><td rowspan="2">Tumor Response as per RECIST v1.1</td><td>Arm A, <i>N</i> = 3</td><td>Arm B, <i>N</i> = 5</td></tr><tr><td>Number of patients</td><td>Number of patients</td></tr><tr><td>CR</td><td>0</td><td>0</td></tr><tr><td>PR</td><td>0</td><td>0</td></tr><tr><td>SD</td><td>1</td><td>2</td></tr><tr><td>PD<... |
de0faa79dbcf7e8985d2eee38ded9875d967b30b6eeb05f295f3fbed4817235a.png | simple | <table><tr><td>Number of eligible patients</td><td>420</td><td>Type of procedure</td></tr><tr><td>Primary procedures</td><td>196</td><td>Aesthetic</td></tr><tr><td><i>n</i> = 378</td><td>131</td><td>Aesthetic and functional</td></tr><tr><td></td><td>51</td><td>Functional</td></tr><tr><td>Revision procedures</td><td>31<... |
b794f34c2276014168e3eba3b280481fc01cb399a605d34ae3df9b61fddc5eae.png | complex | <table><tr><td rowspan="2">Incubation medium [Fe] (mM)</td><td colspan="2">Measured MR relaxation times</td><td colspan="2">Cell function assays</td></tr><tr><td><i>T</i><sub>1</sub> (ms)</td><td><i>T</i><sub>2</sub> (ms)</td><td>Viability (%)</td><td>Proliferation (%)</td></tr><tr><td>0</td><td>2166 ± 135</td><td... |
e4ea7f48434798783f64766449c6ba70aabe8c613aaf523472d6f66a87e2eb59.png | simple | <table><tr><td></td><td>No.</td><td>%</td></tr><tr><td>Gender</td><td></td><td></td></tr><tr><td> Male</td><td>59</td><td>54.13</td></tr><tr><td> Female</td><td>50</td><td>45.87</td></tr><tr><td>Chemotherapy</td><td></td><td></td></tr><tr><td> Gemcitabine alone</td><td>41</td><td>37.61</td></tr><tr><td> Gemcitabine com... |
96c58a2e05c0abda624f057eca277c8d1d6dbfdeb61951498067069ae2dbd20e.png | complex | <table><tr><td>Characteristic</td><td></td><td>Number (<i>n</i>)</td><td>Percentage (%)</td></tr><tr><td rowspan="2">Gender</td><td>Male</td><td>155</td><td>55</td></tr><tr><td>Female</td><td>127</td><td>45</td></tr><tr><td rowspan="2">Gestational age (weeks)</td><td>28–36</td><td>115</td><td>41</td></tr><tr><td>... |
03742c6ae71558770725399ebce166fe97a1cc073a8b397847d2ac94b3fefbbf.png | complex | <table><tr><td rowspan="2">Ash sample</td><td colspan="5">Fraction</td><td rowspan="2">Total</td><td rowspan="2">Total independent measurment</td></tr><tr><td>Water soluble</td><td>Acid soluble/exchangeable</td><td>Reducible</td><td>Oxidizable</td><td>Entrapped in parent matter</td></tr><tr><td>A</td><td>0.0008</td><td... |
6b9b89bdb6892532107600973423ebe4178a13891a8dc77fe4472812e2141a48.png | simple | <table><tr><td>Variable</td><td>Adjusted odds ratio (95% CI)</td><td>SE</td></tr><tr><td>CGPA</td><td>15.27 [6.28, 27.11]<sup><i>∗∗∗</i></sup></td><td>0.88</td></tr><tr><td>Age <30 years</td><td>0.31 [0.06, 1.63]</td><td>0.85</td></tr><tr><td>Male gender</td><td>1.13 [0.50, 2.55]</td><td>0.42</td><... |
c82458e7963c5b5e5a5d30b2651fc8dee50b893dc079c05752090ebcb5a05b41.png | simple | <table><tr><td>Gene names</td><td>RS</td><td>Gene names</td><td>RS</td><td>Gene names</td><td>RS</td></tr><tr><td>KRT19</td><td>1.6</td><td>PTGES2</td><td>0.4</td><td>BCL7C</td><td>0.2</td></tr><tr><td>BARD1</td><td>1.6</td><td>PREX2</td><td>0.4</td><td>ZNF18</td><td>0.2</td></tr><tr><td>MST1R</td><td>1.5</td><td>USP1<... |
adbb04ef5956e742cab0ffb40adf8c2a71e269bc373ef950751315ba02587913.png | complex | <table><tr><td></td><td colspan="2">SNP-database region</td><td></td><td></td></tr><tr><td>Scan-statistic region</td><td>Inter-gene</td><td>Within-gene</td><td>Regions detected only by scan statistic</td><td>Total no. regions</td></tr><tr><td>Non-gene scan statistic</td><td>33 (8)<sup>a</sup></td><td>0</td><td>72 (12)<... |
ebb370375814fc09449cebacbd5fa0242e6084ca67c5f80994b8ef23b0830b53.png | complex | <table><tr><td>Reference</td><td>Country</td><td>Study design</td><td>Sample size</td><td>Data source/sample type</td><td colspan="2">Results</td></tr><tr><td rowspan="3">[30]</td><td rowspan="3">China</td><td rowspan="3">The 5th Chinese National Nutrition and Health Survey (2010–2012)</td><td rowspan="3">2111</t... |
3c950692aabca1421775793445d1b9f1ee1370c495db218d31cc0b239c1c956b.png | simple | <table><tr><td>Theme</td><td>Number of mode-sensitive* items of total number of items</td><td>Median (and maximum)odds ratio among mode-sensitive items</td></tr><tr><td><i>Health behaviour</i></td><td></td><td></td></tr><tr><td>Medicine</td><td>0/3</td><td>-</td></tr><tr><td>Smoking habits</td><td>0/1</td><td>-</td></t... |
01ca6ef05de6969f22c167f644c0a988150c11f69cda0378f41cedcb8570a567.png | complex | <table><tr><td></td><td>Total</td><td>No education</td><td>Primary</td><td>Secondary</td><td>Some college or more</td><td>Ratio: No ed vs. Some college or more</td></tr><tr><td colspan="7">Diabetes</td></tr><tr><td> 1998</td><td>3.72 (3.62, 3.83)</td><td>3.88 (3.65,4.12)</td><td>3.99 (3.84,4.14)</td><td>2.81 (2.48,3.13... |
ed9aeec297a9ef3b747f930b8fe3cfbed7e00e8ca0e3333c6264111908e5d351.png | complex | <table><tr><td> </td><td colspan="4">Risk of bias</td><td colspan="3">Applicability concerns concerns</td></tr><tr><td>First author, year</td><td>Patient selection</td><td>Index test</td><td>Reference standard</td><td>Flow and timing</td><td>Patient selection</td><td>Index test</td><td>Reference standard</td></tr><tr><... |
530157c1a3be3e6a31db27e656665615eee0510c2808d205b2d53102651e6ad8.png | complex | <table><tr><td>Tumor stage</td><td><i>N</i></td><td>(%)</td></tr><tr><td>Non-invasive carcinoma</td><td>24</td><td>8.7</td></tr><tr><td colspan="3"><i>Invasive carcinoma</i></td></tr><tr><td>T1</td><td>176</td><td>61.9</td></tr><tr><td>T2</td><td>63</td><td>22.1</td></tr><tr><td>T3</td><td>9</td><td>3.0</td></tr><tr><t... |
2fe866da159656645f1457b16c67b4381ce93a5cb7fde6992901519cacfe9fd4.png | complex | <table><tr><td>Primers</td><td>5′–3′ sequence (bp)</td><td></td></tr><tr><td colspan="3">Primers for 3′-RACE PCR</td></tr><tr><td>Kiss1-F</td><td>CGCCACAAGCGGCCAAGAAG</td><td></td></tr><tr><td>Kiss2-F</td><td>AGGGCCACATTTCCTGCCGACT</td><td></td></tr><tr><td colspan="3">Primers for 5′-RACE ... |
edb80137ed988cabeaac52890a9029ba836e734ee694fef764cbcc7d1ec8e3b2.png | simple | <table><tr><td>Accession ID</td><td>Amplicon Size</td><td>Primers used</td></tr><tr><td>α ENaC-wt</td><td>325 bp</td><td>Sense: 5'-TCATGCTGCTACGCCGGTTCC-3'</td></tr><tr><td></td><td></td><td>Antisense:5'-TCCATCAGTTTACAAGGGAG-3'</td></tr><tr><td>α ENaC a</td><td>266 bp</td><td>Sense: 5'-CAGAGCTCCTGGGGGCGCCTT-3... |
e848a99bfd5e6afe3ec9a80aae8a7aadf011d081ea63755825161cd1f7c40fca.png | simple | <table><tr><td>Powders Prepared with Different Process Control Agents</td><td>Crystallite Size (nm)</td><td>Lattice Constant (Å)</td><td>Strain (%)</td></tr><tr><td>None</td><td>11.8</td><td>3.1636</td><td>0.688</td></tr><tr><td>Ethanol</td><td>24.2</td><td>3.1549</td><td>0.483</td></tr><tr><td>Stearic acid</td><... |
5ff12fd072b6ba73afdf9c871ff317d28c53fd77b711178c59b12db0230e7915.png | simple | <table><tr><td>Region</td><td>States</td><td>Frequency</td><td>IAQ Practice Indexb</td><td>Schools with index ≥ 70 (%)</td></tr><tr><td>1</td><td>Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont</td><td>25</td><td>71.8</td><td>64</td></tr><tr><td>2</td><td>New Jersey, New York, Puerto Rico,... |
3f20548b64bc1132ce1cb62251541c28fd36b7d6c00c82cc64db87e0f0ca78a4.png | simple | <table><tr><td>Zone</td><td>2008 NBS* Est. U5sfrom 2002 Census</td><td>U5s Registered</td><td>LLINs delivered†</td><td>LLINS issued‡ (%)</td><td>U5s not receiving an LLIN**</td></tr><tr><td>Tanga</td><td>288,185</td><td>N/A††</td><td>402,448</td><td>380,458(94.5)</td><td>0‡‡</td></tr... |
dafd2ca98ad9d1ab89951971db1cf68f8b1fc08271304ef5d003cf8eda53082d.png | complex | <table><tr><td rowspan="2">County</td><td colspan="2">Pre-treatment</td><td colspan="2">Post-treatment</td></tr><tr><td>Number of schools</td><td>Number of children</td><td>Number of schools</td><td>Number of children</td></tr><tr><td>Bomet</td><td>1</td><td>108</td><td>1</td><td>103</td></tr><tr><td>Bungoma</td><td>1<... |
2c0fdafc31416a8ee903f5d0c1b04ad424096b2f608a00351f985b23effdbdd2.png | simple | <table><tr><td></td><td>Patient 1</td><td>Patient 2</td><td>Patient 3</td></tr><tr><td>Origin</td><td>Dominican Republic</td><td>Haiti</td><td>Haiti</td></tr><tr><td>Age (years)</td><td>25</td><td>52</td><td>41</td></tr><tr><td>Sex (W/M)</td><td>W</td><td>W</td><td>M</td></tr><tr><td>Date of diagnosis (and onset of sym... |
545f8a9ff482173bc7bd2e568609d807dbdc5b6480bb0d8efa06ec8a539f9dea.png | complex | <table><tr><td>Domain</td><td>APH</td><td>PPH</td><td>Eclampsia</td></tr><tr><td rowspan="3">Initial assessment & diagnosis</td><td rowspan="3">Per vaginum examination (34%)</td><td rowspan="3">Exploring the uterus for blood clots (39%)</td><td>Weight (4%)</td></tr><tr><td>Swelling on body parts related to severe a... |
9f5329f3f783f64f8498a5e85e05656ad98514c0fa33e567ade50b60e871decb.png | simple | <table><tr><td>Pt nr.</td><td>Max IAP</td><td>Macroscopy</td><td>Microscopy</td><td>Outcome</td></tr><tr><td>1</td><td>22</td><td>Autopsy findings: Focal ischemia on serosal and mucosal side of small bowel</td><td>Mucosa of jejunum and colon almost completely disappeared</td><td>Died 2 days after admission to the ICU</... |
409e0715612752730dc09a90bec367888cf0b4655b318dfe52f444f4e91f66ac.png | complex | <table><tr><td>Parameters</td><td>Score</td><td> </td></tr><tr><td rowspan="2">Acuteness of the first cry</td><td>Absent</td><td>0</td></tr><tr><td>Present</td><td>2</td></tr><tr><td rowspan="2">Burst rhythmicity</td><td>Absent</td><td>0</td></tr><tr><td>Present</td><td>2</td></tr><tr><td rowspan="3">Constancy of the c... |
43f7300236f4d82723910113c4fd611177b1eaab613619144b85b581179cda8c.png | simple | <table><tr><td></td><td>Part 1 (<i>n</i> = 104)</td><td>Part 2 (<i>n</i> = 56)</td></tr><tr><td>Breed [number (%) of cats]</td><td></td><td></td></tr><tr><td>Domestic shorthair cat</td><td>85 (81.6)</td><td>46 (82.1)</td></tr><tr><td>Maine coon</td><td>6 (5.7)</td><td>3 (5.4)</td></tr><tr><td>Norwegian</td><td>4 (3.8)<... |
db39edbee9c25e77b4f67440a523c3840c8c4958d75c182a4842a7918551f474.png | complex | <table><tr><td rowspan="2">Feeding Practices</td><td colspan="2">Age of Introduction of Complementary Foods</td></tr><tr><td><17 Weeks <i>n</i> (%)</td><td>≥17 Weeks <i>n</i> (%)</td></tr><tr><td>Total</td><td>395 (62.5)</td><td>237 (37.5)</td></tr><tr><td colspan="3">Explanations given for introducing solid f... |
5d1e389cec720b66822eb8b0d59a66591621ea377ccded3b72d9792331884b98.png | complex | <table><tr><td> </td><td colspan="2">Right Knee</td><td> </td><td> </td><td colspan="2">Left Knee</td><td> </td><td> </td></tr><tr><td> </td><td>Before</td><td>After</td><td><i>P</i></td><td>Effect size</td><td>Before</td><td>After</td><td><i>P</i></td><td>Effect size</td></tr><tr><td>KIN (n = 16)</td><td>6.9 ± 1.... |
79c938375298aa138f1c58fddb5c402dfd06019b15b6fc62a4801bfa52ae2c22.png | simple | <table><tr><td></td><td>Positive keywords</td><td>Negative keywords</td></tr><tr><td>BTE</td><td>mould, be34, map, gp, 92, audio, inf, be52, ref, staff, reqd, be36, contact</td><td>fta, reshel, appt, it, nn, nfa, 2001, rev, lacquer, hn, km, imp, review, 2000</td></tr><tr><td>ITE</td><td>fta, reshel, appt, it, nn, nfa, ... |
681d38e2c308825a62b0b547a3d6e519e686df060c63ebf681d673941d4dc637.png | complex | <table><tr><td colspan="10">A. Regions from first iteration analyses</td></tr><tr><td colspan="3">Degree of damage to each ROI</td><td colspan="3">Analysis with Fuzzy images</td><td colspan="4">Analysis with Binary images</td></tr><tr><td>Group</td><td>Temporal ROI</td><td>Frontal ROI</td><td>n</td><td>Impaired</td><td... |
2ad758ee4e601bd0d564f58348e4245bd0cbca8c2565c18094b1d46dc0d97098.png | complex | <table><tr><td></td><td>Age</td><td colspan="3">Southern Coastal plain(Yoto)</td><td colspan="3">Central Plateaux(Ogou)</td><td colspan="3">Northern Savannah(Tone)</td></tr><tr><td></td><td>mo</td><td>2004%</td><td>2005%</td><td>RR (95%CI)</td><td>2004%</td><td>2005%</td><td>RR (95%CI)</td><td>2004%</td><td>2005%</td><... |
df44b013f80e6e277589ff1b0478e3a3d91132aba3d80da85315c04201443f91.png | complex | <table><tr><td></td><td>+</td><td>−</td></tr><tr><td colspan="3">NEURAL ACTIVITY</td></tr><tr><td>Spontaneous activity</td><td></td><td></td></tr><tr><td> Electro-physiology</td><td>Basta and Ernst (90), Jastreboff and Sasaki (87), and Manabe et al. (91)</td><td>Ma et al. (92)</td></tr><tr><td> Metabolicmarkers</... |
b0bf5328cb063cfee409037e3fb9d9dde8c0aee4ff87f0c2d4ff688cab9fcf32.png | complex | <table><tr><td></td><td>Baseline</td><td colspan="2">HD</td><td colspan="2">H60</td><td colspan="2">S60</td></tr><tr><td></td><td></td><td>PEG-albumin</td><td>HES</td><td>PEG-albumin</td><td>HES</td><td>PEG-albumin</td><td>HES</td></tr><tr><td>Hematocrit (%)</td><td>46.4 ± 1.4</td><td>26.4 ± 0.9*<sup>b</sup><... |
632719cc3d1a359e36170b4615329293200f40f91f48d96a914bc56cb693c9b7.png | simple | <table><tr><td></td><td>N = 134</td><td>(%)</td></tr><tr><td>Food reactions</td><td></td><td></td></tr><tr><td>Gastro-intestinal symptoms</td><td>67</td><td>(50)</td></tr><tr><td>OAS – Oral Allergy Syndrome</td><td>63</td><td>(47)</td></tr><tr><td>Difficulty breathing</td><td>53</td><td>(40)</td></tr><tr><td>Skin... |
11bf9951ed5e1a7f6942e1921fc6304550ebb03f5086c42e30b0ec6e602e9ebf.png | complex | <table><tr><td></td><td></td><td>Cases (%)</td><td>Controls (%)</td></tr><tr><td colspan="4">Gender</td></tr><tr><td></td><td>Male</td><td>463 (58%)</td><td>423 (53%)</td></tr><tr><td></td><td>Female</td><td>334 (42%)</td><td>370 (47%)</td></tr><tr><td colspan="4">Age group (years)</td></tr><tr><td></td><td>20-49</td><... |
6632dbe11832ab2bfb7f71c6f502a2b7c01efcf59e4c8bc368fd70b34022545f.png | complex | <table><tr><td></td><td>Number of airlines</td></tr><tr><td colspan="2">Pre-boarding arrangements</td></tr><tr><td>• Request a food “buffer zone”</td><td>5</td></tr><tr><td>• No “buffer zone”</td><td>3</td></tr><tr><td>• Request “allergen-free meal”</td><td>1</td></... |
f2f0112bcad693a028c723e4f298815614bd21d6c0ee02112455b220fd390312.png | complex | <table><tr><td>Risk category</td><td>Criteria</td><td>Age to commence screening</td><td>Screening Test</td><td>Screening frequency (years)</td></tr><tr><td rowspan="3">Average-risk(Age-only)</td><td rowspan="3">Age 50–74 years</td><td rowspan="3">50</td><td>FOBT</td><td>2</td></tr><tr><td>Sigmoidoscopy</td><td>5<... |
11514fae5f9423d893e803a6cf7a0eafbce74345556a552f492cca2c181a8aa0.png | complex | <table><tr><td>Targeted Gene</td><td>Primer</td><td>Sequence (5′–3′)</td></tr><tr><td rowspan="2">ALDOA</td><td>Forward</td><td>ATGCCCTACCAATATCCAGC</td></tr><tr><td>Reverse</td><td>GACAGCCCATCCAACCCT</td></tr><tr><td rowspan="2">CDC20</td><td>Forward</td><td>GGCACCAGTGATCGACACATTCGCAT</td></tr><tr><t... |
a270f231ac307b3e481e762cbd4de0bcc73ec2472e01530dbbbbdfd21a4f2a72.png | simple | <table><tr><td>Resistance pattern to the NARMS antimicrobial panel</td><td>% of isolates with resistance profile (no.)</td><td>Plasmid profile groups detected (no.)<sup>a</sup></td><td>Species of isolates with plasmids (no.)</td><td>PFGE patterns</td></tr><tr><td>STR, FIS, TET, SXT</td><td>33% (14)</td><td>II, X(3), VI... |
7c76b8a59b7a860439ce9a9521cbba8fa3d773cdb5f545d589e99629573744b7.png | complex | <table><tr><td rowspan="3"></td><td colspan="5">Disability in 2012 (%)</td></tr><tr><td rowspan="2">All <i>n</i> (%)</td><td colspan="2">No FOF in 2012</td><td colspan="2">Having FOF in 2012</td></tr><tr><td>No FOF in 2010</td><td>Having FOF in 2010</td><td>No FOF in 2010</td><td>Having FOF in 2010</td></tr><tr><td>Pre... |
b03c671653f44c48a83b4e8791e5c4e90016519c5ac2f0417420bf69e511bbaf.png | complex | <table><tr><td></td><td colspan="2">Putative fox feces</td><td colspan="2">Locations</td></tr><tr><td></td><td>Number of samples</td><td>Positive samples (%)</td><td>Number of locations</td><td>Positive locations (%)</td></tr><tr><td>Anatolia</td><td>186</td><td>7 (3.8)</td><td>59</td><td>3 (5.1)</td></tr><tr><td>Thrac... |
ef90399023416d0219564f3273e662220ccb1d94fd7f309022532ee0de951e7e.png | complex | <table><tr><td>Characteristics</td><td>No. of patients</td><td colspan="2">Expression of CIP2A</td><td><i>P</i>value</td></tr><tr><td> </td><td> </td><td>Low, n (%)</td><td>High, n (%)</td><td> </td></tr><tr><td>Age</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>≤45</td><td>130</td><td>48 (50)</td><td>8... |
0065bcbd987c65f4941e449b9083469577f34870a6b3f8839911bb1c97eabce7.png | complex | <table><tr><td></td><td>Early differentiation</td><td>Intermediate differentiation</td><td>Terminal differentiation</td></tr><tr><td colspan="4">Phenotypic markers</td></tr><tr><td>CD28</td><td>++</td><td>+/−</td><td>–</td></tr><tr><td>CD27</td><td>++</td><td>+/−</td><td>–</td></tr><tr><td>CD45R... |
4f32026ce8c83dab76977e207c1724e23b8c1663d4f2469139d4b7ba4bc8f61b.png | complex | <table><tr><td>Amendment</td><td>Concentration</td><td>m<sub>N</sub><sup>a</sup></td><td>Effectiveness</td></tr><tr><td rowspan="3">Aldrich Humic Acid</td><td>1 mg C L<sup>-1</sup></td><td>0.7(0)</td><td>LS</td></tr><tr><td>5 mg C L<sup>-1</sup></td><td>0.3(6)</td><td>LS</td></tr><tr><td>10 mg C L<sup>-1</sup></td><td>... |
95598a4906a9f2c28b112b5dc5e76dbaacc3482b41f077e1ab5c1bb3baa54f89.png | complex | <table><tr><td>Variable</td><td>HBV</td><td>%</td><td><i>Odds ratio</i></td><td><i>p</i></td></tr><tr><td>Year</td><td>Positive/Total</td><td> </td><td>(95% CI)</td><td> </td></tr><tr><td>2001*</td><td>52/552</td><td>9.42</td><td rowspan="2">3.31 (2.40-4.57)</td><td rowspan="2">< 0.01</td></tr><tr><td>2010</td><td>2... |
dc5f675f4652ba6ae5481e47b21a80c122a7fdb6148f8729afb7260178fba33c.png | simple | <table><tr><td>Chromosome</td><td>AntiSMASH</td><td>SMURF</td><td>Unique NP</td></tr><tr><td>I</td><td>1</td><td>1</td><td>1</td></tr><tr><td>II</td><td>3</td><td>1</td><td>4</td></tr><tr><td>III</td><td>4</td><td>4</td><td>5</td></tr><tr><td>IV</td><td>3</td><td>1</td><td>4</td></tr><tr><td>V</td><td>6</td><td>6</td><... |
8732a491314a5b2c62f2b500a195bcbc0d6fe51f048273e065e58829c489ca92.png | complex | <table><tr><td></td><td>n (%)</td></tr><tr><td colspan="2">Primary clinical composite diagnoses</td></tr><tr><td> Anterior cruciate ligament injury</td><td>8 (5)</td></tr><tr><td> Meniscal injury</td><td>36 (20)</td></tr><tr><td> Patellofemoral Pain Syndrome</td><td>45 (25)</td></tr><tr><td> Osteoarthritis</td><td>79 (... |
e5c92916e322f51d50e3ee07a141fd653d793e92a556cf59be026ed562606f01.png | simple | <table><tr><td></td><td>0d</td><td>3d</td><td>6d</td><td>9d</td><td>12d</td><td>15d</td><td>18d</td><td>21d</td><td>24d</td><td>27d</td><td>30d</td><td>33d</td><td>36d</td><td>39d</td><td>42d</td><td>45d</td><td>48d</td><td>51d</td><td>54d</td><td>57d</td><td>60d</td><td>63d</td><td>≥ 66d</td></tr><tr><td># of CT... |
6924d401fd0b856d3b289ec313931fbf18aba667109ab648748c653444575e97.png | complex | <table><tr><td rowspan="3">Part of Intestine</td><td colspan="2">Control group</td><td colspan="2">Pomegranate treated group</td><td colspan="2">Sodium.butyrate treated group</td></tr><tr><td>Non-everted (μg)</td><td>Everted (μg)</td><td>Non-everted (μg)</td><td>Everted (μg)</td><td>Non-everted (	... |
a309c6393b5461670b9ec048aa56a98d53815eb0322080d5df2287b6280252e7.png | simple | <table><tr><td></td><td>Discharged</td><td>Expired</td></tr><tr><td></td><td>32</td><td>18</td></tr><tr><td>Tracheostomy</td><td>26.5</td><td>23.5</td></tr><tr><td></td><td>1.141</td><td>1.30</td></tr><tr><td></td><td>21</td><td>29</td></tr><tr><td>Non Tracheostomy</td><td>26.5</td><td>23.5</td></tr><tr><td></td><td>1.... |
6f6adfe73321e5611bfa59a161cb2012a61f77c5576d7196431723a739c49a34.png | simple | <table><tr><td> </td><td>BRCA1</td><td>BRCA2</td><td>Non-BRCA1/2</td></tr><tr><td>All males in kConFab registry</td><td>429</td><td>339</td><td>19137</td></tr><tr><td>Breast Cancers</td><td>5 (1.2%)</td><td>35 (10.3%)</td><td>78 (0.4%)</td></tr><tr><td>Pathology Available</td><td>3</td><td>25</td><td>32</td></tr></tabl... |
2464281b7e42f8d8c51dcb219b3896d4f3f43b65f3da349a9e6c734c7d9a1f24.png | simple | <table><tr><td>Patients with HPA</td><td>Gender</td><td>Age</td><td>Mechanism of trauma</td><td>Liver injury grade*</td><td>Symptoms of HPA</td><td>Blood transfusion</td></tr><tr><td>1</td><td>Female</td><td>25</td><td>Blunt</td><td>2</td><td>No</td><td>No</td></tr><tr><td>2</td><td>Male</td><td>20</td><td>Blunt</td><t... |
0cd07bfd47076ea2d32ce6e52a11eba8e6155b4c2743aa9aad0f840ba470b286.png | simple | <table><tr><td>Age groups of Males/females </td><td>Quantity of interviewees</td></tr><tr><td>50-60 (10 males)</td><td>10</td></tr><tr><td>63-69 (20 males/5 females)</td><td>25</td></tr><tr><td>70-75 (10 male hakims/7 females)</td><td>17</td></tr><tr><td>75-80 (8 female)</td><td>8</td></tr></table> |
da1454e4a51c2473b02bc0994f853e83fda54124b2f2a6b0fa59377c1236bfc7.png | simple | <table><tr><td>Gene <sup>a</sup></td><td>Region</td><td>Size</td><td>Inc <sup>b</sup></td><td>AT%</td><td>AT-Skew <sup>c</sup></td><td>GC-Skew</td><td>Start Codon</td><td>Stop Codon</td><td>Anticodon</td></tr><tr><td><i>cox1</i></td><td>1–1539</td><td>1539</td><td>1</td><td>64.39</td><td>−0.322</td><td>0.26... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.